Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 48 | 2024 | 2475 | 3.810 |
Why?
|
Early Detection of Cancer | 46 | 2024 | 3086 | 3.120 |
Why?
|
Breast Neoplasms | 63 | 2024 | 20824 | 2.430 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 12 | 2023 | 948 | 1.290 |
Why?
|
Mass Screening | 28 | 2023 | 5253 | 1.270 |
Why?
|
Breast | 14 | 2024 | 1970 | 0.910 |
Why?
|
Models, Statistical | 21 | 2020 | 5101 | 0.780 |
Why?
|
Direct Service Costs | 2 | 2014 | 62 | 0.770 |
Why?
|
Computer Simulation | 20 | 2023 | 6194 | 0.670 |
Why?
|
Cost-Benefit Analysis | 19 | 2022 | 5388 | 0.640 |
Why?
|
Quality-Adjusted Life Years | 12 | 2022 | 1683 | 0.640 |
Why?
|
Receptors, Estrogen | 5 | 2024 | 2190 | 0.510 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2015 | 387 | 0.470 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.460 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1265 | 0.460 |
Why?
|
False Positive Reactions | 9 | 2021 | 980 | 0.360 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 2020 | 1100 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2022 | 9240 | 0.350 |
Why?
|
Magnetic Resonance Imaging | 11 | 2024 | 35425 | 0.350 |
Why?
|
Diagnostic Imaging | 5 | 2021 | 3508 | 0.330 |
Why?
|
Neonatal Screening | 3 | 2023 | 591 | 0.330 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2017 | 2020 | 0.330 |
Why?
|
Calibration | 3 | 2015 | 816 | 0.330 |
Why?
|
Female | 78 | 2024 | 380193 | 0.320 |
Why?
|
Genetic Testing | 5 | 2023 | 3444 | 0.310 |
Why?
|
Canada | 4 | 2018 | 2065 | 0.310 |
Why?
|
Aged | 49 | 2024 | 163288 | 0.290 |
Why?
|
Adult | 49 | 2024 | 214052 | 0.280 |
Why?
|
Models, Theoretical | 6 | 2019 | 3589 | 0.280 |
Why?
|
Registries | 8 | 2023 | 8091 | 0.280 |
Why?
|
Middle Aged | 52 | 2024 | 213390 | 0.270 |
Why?
|
Sensitivity and Specificity | 15 | 2021 | 14723 | 0.250 |
Why?
|
Decision Support Techniques | 6 | 2020 | 1956 | 0.250 |
Why?
|
Humans | 92 | 2024 | 744366 | 0.240 |
Why?
|
Down Syndrome | 2 | 2023 | 880 | 0.240 |
Why?
|
United States | 38 | 2024 | 69872 | 0.230 |
Why?
|
Leukemia | 2 | 2022 | 1510 | 0.230 |
Why?
|
Incidence | 14 | 2021 | 20952 | 0.220 |
Why?
|
Carcinoma, Lobular | 2 | 2018 | 484 | 0.220 |
Why?
|
Ontario | 5 | 2022 | 383 | 0.220 |
Why?
|
Risk Assessment | 12 | 2021 | 23336 | 0.210 |
Why?
|
Mastectomy, Segmental | 3 | 2018 | 956 | 0.210 |
Why?
|
Patient Acceptance of Health Care | 2 | 2015 | 3020 | 0.200 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2022 | 114 | 0.200 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2021 | 48 | 0.190 |
Why?
|
Models, Biological | 7 | 2018 | 9584 | 0.190 |
Why?
|
Age Distribution | 5 | 2020 | 2902 | 0.190 |
Why?
|
Neoplasm Staging | 9 | 2018 | 11031 | 0.180 |
Why?
|
Community Health Services | 2 | 2017 | 650 | 0.170 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7282 | 0.170 |
Why?
|
Ultrasonography, Mammary | 2 | 2023 | 250 | 0.160 |
Why?
|
Young Adult | 14 | 2023 | 56429 | 0.150 |
Why?
|
Neoplasms | 6 | 2022 | 21696 | 0.150 |
Why?
|
Unnecessary Procedures | 1 | 2020 | 432 | 0.140 |
Why?
|
SEER Program | 6 | 2018 | 1507 | 0.140 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.140 |
Why?
|
Age Factors | 7 | 2018 | 18373 | 0.140 |
Why?
|
Life Tables | 1 | 2015 | 370 | 0.130 |
Why?
|
British Columbia | 1 | 2015 | 244 | 0.130 |
Why?
|
Patient Participation | 2 | 2015 | 1457 | 0.130 |
Why?
|
Decision Making | 4 | 2015 | 3888 | 0.130 |
Why?
|
Chemoprevention | 1 | 2017 | 319 | 0.120 |
Why?
|
Cohort Studies | 11 | 2021 | 40559 | 0.120 |
Why?
|
Tamoxifen | 2 | 2022 | 981 | 0.120 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 806 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1265 | 0.120 |
Why?
|
Women's Health | 2 | 2018 | 2034 | 0.120 |
Why?
|
Receptors, Progesterone | 1 | 2018 | 1098 | 0.110 |
Why?
|
Survivors | 2 | 2022 | 2291 | 0.110 |
Why?
|
Mastectomy, Modified Radical | 1 | 2013 | 62 | 0.110 |
Why?
|
Child | 15 | 2023 | 77709 | 0.110 |
Why?
|
Biopsy | 4 | 2021 | 6755 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 402 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 7914 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2023 | 57776 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 895 | 0.110 |
Why?
|
Watchful Waiting | 1 | 2017 | 492 | 0.110 |
Why?
|
Health Status Disparities | 1 | 2023 | 1796 | 0.100 |
Why?
|
Radiographic Image Enhancement | 2 | 2014 | 885 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 264 | 0.100 |
Why?
|
Papillomavirus Vaccines | 2 | 2008 | 491 | 0.100 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 680 | 0.100 |
Why?
|
Colposcopy | 2 | 2008 | 144 | 0.100 |
Why?
|
Life Expectancy | 3 | 2017 | 1184 | 0.100 |
Why?
|
Pharmacogenetics | 1 | 2015 | 674 | 0.100 |
Why?
|
Asthma | 3 | 2015 | 6010 | 0.090 |
Why?
|
Mortality | 5 | 2024 | 2864 | 0.090 |
Why?
|
Genes, BRCA2 | 1 | 2014 | 618 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15078 | 0.090 |
Why?
|
Quality of Life | 3 | 2017 | 12802 | 0.090 |
Why?
|
Helicobacter pylori | 1 | 2013 | 383 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 781 | 0.090 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6773 | 0.090 |
Why?
|
Helicobacter Infections | 1 | 2013 | 387 | 0.090 |
Why?
|
Empirical Research | 1 | 2010 | 120 | 0.090 |
Why?
|
Cost Savings | 1 | 2015 | 925 | 0.090 |
Why?
|
Time Factors | 10 | 2017 | 40075 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17446 | 0.090 |
Why?
|
DNA Probes, HPV | 1 | 2008 | 21 | 0.080 |
Why?
|
Risk Factors | 13 | 2023 | 72296 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1099 | 0.080 |
Why?
|
Air Pollution, Indoor | 2 | 2013 | 857 | 0.080 |
Why?
|
Human papillomavirus 16 | 2 | 2008 | 262 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2375 | 0.080 |
Why?
|
Prognosis | 4 | 2021 | 29060 | 0.070 |
Why?
|
Radiography | 3 | 2023 | 7023 | 0.070 |
Why?
|
Papillomavirus Infections | 2 | 2010 | 1587 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1997 | 0.070 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1405 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1856 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1711 | 0.070 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2018 | 288 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2023 | 77460 | 0.060 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 221 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2023 | 25628 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5321 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1524 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2013 | 1332 | 0.060 |
Why?
|
Wisconsin | 2 | 2018 | 124 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2015 | 3154 | 0.060 |
Why?
|
Infant | 5 | 2023 | 35134 | 0.050 |
Why?
|
Economics, Medical | 1 | 2022 | 113 | 0.050 |
Why?
|
Triage | 1 | 2008 | 977 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4557 | 0.050 |
Why?
|
Adolescent | 9 | 2022 | 85779 | 0.050 |
Why?
|
Medical Informatics Computing | 1 | 2001 | 25 | 0.050 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2417 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4042 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2023 | 20130 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2018 | 1771 | 0.050 |
Why?
|
Forecasting | 2 | 2022 | 2951 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2021 | 275 | 0.040 |
Why?
|
Decision Trees | 2 | 2017 | 506 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Radiation, Ionizing | 1 | 2019 | 258 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2021 | 375 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9312 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2012 | 4232 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1534 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12788 | 0.040 |
Why?
|
Population Surveillance | 2 | 2021 | 2616 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2017 | 11126 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13693 | 0.040 |
Why?
|
Ultrasonography | 2 | 2021 | 5984 | 0.040 |
Why?
|
Occult Blood | 1 | 2017 | 176 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9688 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 25039 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 547 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 8987 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.030 |
Why?
|
Child, Preschool | 4 | 2021 | 41005 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2740 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11525 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3531 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6364 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2019 | 2031 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13286 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3252 | 0.030 |
Why?
|
Male | 11 | 2021 | 350115 | 0.030 |
Why?
|
Head | 1 | 2019 | 880 | 0.030 |
Why?
|
Pest Control | 1 | 2013 | 30 | 0.030 |
Why?
|
Medical History Taking | 1 | 2017 | 784 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 969 | 0.030 |
Why?
|
Abdomen | 1 | 2019 | 1118 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1094 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2001 | 2307 | 0.030 |
Why?
|
Universities | 1 | 2018 | 951 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.030 |
Why?
|
Stochastic Processes | 2 | 2006 | 344 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2014 | 3480 | 0.030 |
Why?
|
Spine | 1 | 2019 | 1144 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2015 | 1105 | 0.030 |
Why?
|
Prenatal Care | 1 | 2019 | 1092 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21748 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.030 |
Why?
|
Feces | 1 | 2017 | 1401 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2949 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2001 | 1164 | 0.020 |
Why?
|
Particulate Matter | 2 | 2013 | 2529 | 0.020 |
Why?
|
Public Housing | 1 | 2012 | 145 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2015 | 705 | 0.020 |
Why?
|
Colonoscopy | 1 | 2019 | 1367 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3493 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39052 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13991 | 0.020 |
Why?
|
Nitrogen Dioxide | 1 | 2012 | 490 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Advisory Committees | 1 | 2014 | 775 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1438 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2602 | 0.020 |
Why?
|
Air Pollutants | 2 | 2013 | 2816 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13882 | 0.020 |
Why?
|
Anti-Asthmatic Agents | 1 | 2012 | 536 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2540 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2013 | 1680 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2012 | 1745 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3582 | 0.020 |
Why?
|
Models, Econometric | 1 | 2008 | 218 | 0.020 |
Why?
|
Human papillomavirus 18 | 1 | 2008 | 128 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1915 | 0.020 |
Why?
|
Cardiology | 1 | 2018 | 1668 | 0.020 |
Why?
|
Software | 1 | 2001 | 4441 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1125 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1660 | 0.020 |
Why?
|
Prevalence | 2 | 2017 | 15221 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 63107 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53290 | 0.020 |
Why?
|
Medicare | 2 | 2017 | 6566 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8319 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12356 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3611 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3056 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13409 | 0.010 |
Why?
|
Mammaplasty | 1 | 2013 | 1204 | 0.010 |
Why?
|
Brazil | 1 | 2007 | 1270 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 5984 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1184 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2265 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7730 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2007 | 1254 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9955 | 0.010 |
Why?
|
DNA, Viral | 1 | 2008 | 2227 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2013 | 2071 | 0.010 |
Why?
|
Medication Adherence | 1 | 2012 | 2063 | 0.010 |
Why?
|
Poverty | 1 | 2012 | 2660 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.010 |
Why?
|
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_